{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Rotavirus+Vaccine", "query": { "intervention": "Rotavirus Vaccine" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 35, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Rotavirus+Vaccine&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-02T07:27:18.889Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06736041", "title": "Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pneumococcal Immunization" ], "interventions": [ { "name": "PCV21 vaccine", "type": "BIOLOGICAL" }, { "name": "Prevnar 20 vaccine", "type": "BIOLOGICAL" }, { "name": "M-M-R II vaccine", "type": "BIOLOGICAL" }, { "name": "RotaTeq", "type": "BIOLOGICAL" }, { "name": "Vaxelis vaccine", "type": "BIOLOGICAL" }, { "name": "Varivax", "type": "BIOLOGICAL" }, { "name": "Hexaxim Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "89 Days", "sex": "ALL", "summary": "42 Days to 89 Days" }, "enrollment_count": 1714, "start_date": "2024-12-18", "completion_date": "2027-05-17", "has_results": false, "last_update_posted_date": "2026-04-22", "last_synced_at": "2026-09-02T07:27:18.889Z", "location_count": 66, "location_summary": "Glendale, Arizona • Tucson, Arizona • Fayetteville, Arkansas + 48 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Huntington Park", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06736041" }, { "nct_id": "NCT01000974", "title": "Consistency & Immunogenicity Study of 3 Lots of GSK's Hib Conjugate Vaccine Versus ActHIB & Pentacel in Healthy Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Haemophilus Influenzae Type b" ], "interventions": [ { "name": "GSK Biologicals' Haemophilus influenzae type b vaccine (GSK 208108)", "type": "BIOLOGICAL" }, { "name": "ActHIB™", "type": "BIOLOGICAL" }, { "name": "Pentacel™", "type": "BIOLOGICAL" }, { "name": "Pediarix™", "type": "BIOLOGICAL" }, { "name": "Prevnar 13™", "type": "BIOLOGICAL" }, { "name": "Rotarix™", "type": "BIOLOGICAL" }, { "name": "Engerix™-B", "type": "BIOLOGICAL" }, { "name": "Infanrix™", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 4003, "start_date": "2010-06-18", "completion_date": "2013-07-17", "has_results": true, "last_update_posted_date": "2018-07-12", "last_synced_at": "2026-09-02T07:27:18.889Z", "location_count": 63, "location_summary": "Dothan, Alabama • Benton, Arkansas • Fayetteville, Arkansas + 59 more", "locations": [ { "city": "Dothan", "state": "Alabama" }, { "city": "Benton", "state": "Arkansas" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01000974" }, { "nct_id": "NCT03954743", "title": "Safety Study of 2 Formulations of GSK's Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Infections, Rotavirus" ], "interventions": [ { "name": "PCV-free liquid formulation of GSK's oral live attenuated HRV vaccine", "type": "BIOLOGICAL" }, { "name": "Lyophilized formulation of GSK's oral live attenuated HRV vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 1351, "start_date": "2019-07-19", "completion_date": "2020-11-30", "has_results": true, "last_update_posted_date": "2022-03-10", "last_synced_at": "2026-09-02T07:27:18.889Z", "location_count": 19, "location_summary": "Birmingham, Alabama • Colorado Springs, Colorado • Louisville, Kentucky + 14 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Frederick", "state": "Maryland" }, { "city": "Fall River", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT03954743" }, { "nct_id": "NCT01542320", "title": "Effect of Probiotic Supplementation on Immune Function in Healthy Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Inflammation" ], "interventions": [ { "name": "Lactobacillus reuteri DSM 17938", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "32 Weeks", "sex": "ALL", "summary": "6 Weeks to 32 Weeks" }, "enrollment_count": 15, "start_date": "2012-03", "completion_date": "2014-12", "has_results": false, "last_update_posted_date": "2015-03-06", "last_synced_at": "2026-09-02T07:27:18.889Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01542320" }, { "nct_id": "NCT06485258", "title": "CDC-9 Inactivated Rotavirus Vaccine (IRV) Intramuscular (IM) Phase 1 Clinical Trial in Healthy Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Rotavirus Infections" ], "interventions": [ { "name": "3.75 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV)", "type": "BIOLOGICAL" }, { "name": "7.5 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Centers for Disease Control and Prevention", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 50, "start_date": "2024-08-06", "completion_date": "2026-02-04", "has_results": false, "last_update_posted_date": "2026-05-26", "last_synced_at": "2026-09-02T07:27:18.889Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06485258" }, { "nct_id": "NCT02542462", "title": "Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Intussusception", "Rotavirus Infections" ], "interventions": [ { "name": "Rotarix®,", "type": "DRUG" }, { "name": "Rotarix®, with other routine vaccines", "type": "DRUG" }, { "name": "RotaTeq®,", "type": "DRUG" }, { "name": "RotaTeq®, with other routine vaccines", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Children's Hospital Medical Center, Cincinnati", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "90 Days", "sex": "ALL", "summary": "42 Days to 90 Days" }, "enrollment_count": 144, "start_date": "2015-11", "completion_date": "2017-05", "has_results": true, "last_update_posted_date": "2018-07-12", "last_synced_at": "2026-09-02T07:27:18.889Z", "location_count": 1, "location_summary": "Cincinnati, Ohio", "locations": [ { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT02542462" }, { "nct_id": "NCT00995813", "title": "Pilot Study of the Rotavirus Vaccine in Infants With Intestinal Failure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Intestinal Failure", "Rotavirus Vaccines" ], "interventions": [ { "name": "Rotarix", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Seattle Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "14 Weeks", "sex": "ALL", "summary": "6 Weeks to 14 Weeks" }, "enrollment_count": 15, "start_date": "2009-12", "completion_date": "2013-07", "has_results": false, "last_update_posted_date": "2015-11-18", "last_synced_at": "2026-09-02T07:27:18.889Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00995813" }, { "nct_id": "NCT00334607", "title": "Study of 2 Doses of HRV Vaccine Given Concomitantly or Separately With Routine Vaccinations in Healthy Infants in USA", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Infections, Rotavirus" ], "interventions": [ { "name": "2-dose oral live attenuated G1P[8] human rotavirus vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "16 Weeks", "sex": "ALL", "summary": "6 Weeks to 16 Weeks" }, "enrollment_count": 484, "start_date": "2006-06", "completion_date": "2007-06", "has_results": false, "last_update_posted_date": "2016-11-04", "last_synced_at": "2026-09-02T07:27:18.889Z", "location_count": 42, "location_summary": "Benton, Arkansas • Cabot, Arkansas • Jonesboro, Arkansas + 37 more", "locations": [ { "city": "Benton", "state": "Arkansas" }, { "city": "Cabot", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "North Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00334607" }, { "nct_id": "NCT06962904", "title": "CDC-9 Inactivated Rotavirus Vaccine (IRV) Microneedle Patch (MNP) in Healthy Adults", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Rotavirus Infections" ], "interventions": [ { "name": "3.75 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV)", "type": "BIOLOGICAL" }, { "name": "7.5 µg Dose of CDC-9 Inactivated Rotavirus Vaccine (IRV)", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "BIOLOGICAL", "OTHER" ], "sponsor": "Centers for Disease Control and Prevention", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 50, "start_date": "2025-07-07", "completion_date": "2026-10-06", "has_results": false, "last_update_posted_date": "2026-03-05", "last_synced_at": "2026-09-02T07:27:18.889Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT06962904" }, { "nct_id": "NCT06397768", "title": "Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "RSV Immunization" ], "interventions": [ { "name": "RSVt vaccine", "type": "BIOLOGICAL" }, { "name": "Diphtheria, tetanus, pertussis, poliomyelitis , Haemophilus influenzae type b, and hepatitis B vaccine", "type": "BIOLOGICAL" }, { "name": "Diphtheria, tetanus, pertussis, Haemophilus influenzae type b and poliomyelitis vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis B vaccine", "type": "BIOLOGICAL" }, { "name": "Streptococcus pneumoniae vaccine", "type": "BIOLOGICAL" }, { "name": "Rotavirus vaccine", "type": "BIOLOGICAL" }, { "name": "Measles, mumps, and rubella vaccine", "type": "BIOLOGICAL" }, { "name": "Varicella virus vaccine", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Months", "maximum_age": "12 Months", "sex": "ALL", "summary": "6 Months to 12 Months" }, "enrollment_count": 2226, "start_date": "2024-05-13", "completion_date": "2025-09-18", "has_results": false, "last_update_posted_date": "2026-02-03", "last_synced_at": "2026-09-02T07:27:18.889Z", "location_count": 66, "location_summary": "Birmingham, Alabama • Grand Bay, Alabama • Mobile, Alabama + 55 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Grand Bay", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Bell Gardens", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06397768" } ] }